Paul Bridges, Ph.D.

Paul Bridges is President of Parexel's Consulting organization, comprising Access Consulting, Regulatory Consulting, Strategic Compliance, Medical Communications – as well as Health Advances and The Medical Affairs Company (TMAC). In this role, he leads a global team of more than 2,100 colleagues including 80+ former regulators and HTA professionals. Parexel’s Consulting businesses support decision-making to minimize risk and maximize the probability of commercial success.

In his nearly two decades with Parexel, Paul’s experience includes serving as Vice President, European Account Management for Parexel Consulting as well as Senior Director of the consultancy’s regional UK Integrated Product Development (IPD) Consulting team. He joined the organization as a Principal Consultant providing strategic regulatory advice on all aspects of drug development with a special focus on Chemistry, Manufacturing and Controls (CMC).

Prior to Parexel, Paul was the European Director of Regulatory Affairs for INO Therapeutics and a pharmaceutical assessor for the UK Licensing Authority (MCA) with specific expertise in CMC. He has extensive knowledge of European licensing procedures from the perspective of both industry and regulatory authorities covering diverse therapeutic areas.

As part of his Ph.D. program, Paul studied the pulmonary delivery of drugs and has published work in this field. He is a member of the British Institute of Regulatory Affairs, the European Society of Regulatory Affairs, the Royal Pharmaceutical Society of Great Britain and the Royal Society of Medicine.